文献速递妇产影像技术与安全PETCT

18F-FDG PET/CT 体积代谢参数对子宫颈癌的预后价值:系统评价与 Meta 分析

Prognostic Value of Volume-Based Metabolic Parameters of 18F-FDG PET/CT in Uterine Cervical Cancer: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJR Am J Roentgenol · 2018-09-12

该系统评价与 Meta 分析纳入 12 项研究共 660 例子宫颈癌患者,评估治疗前 MTV 和 TLG 对无事件生存和总生存的预后价值。高 MTV 和 TLG 患者预后更差,EFS 的合并 HR 分别为 5.89 和 5.82,OS 的合并 HR 分别为 6.62 和 7.75,亚组分析中 MTV 和 TLG 对 EFS 的预后价值持续显著。

要点

  • 治疗前高 MTV 或高 TLG 的子宫颈癌患者无事件生存和总生存均更差。
  • EFS 合并 HR:MTV 5.89(95%CI 3.85-9.01),TLG 5.82(95%CI 3.62-9.35)。
  • OS 合并 HR:MTV 6.62(95%CI 3.44-12.73),TLG 7.75(95%CI 3.48-17.27)。

核心结论

  • 基于体积的 FDG PET/CT 参数是子宫颈癌患者的显著预后因素,尽管研究间存在临床和方法学差异,高 MTV 或 TLG 患者发生不良事件或死亡的风险更高。

研究设计与样本

  • 系统评价与 Meta 分析,系统检索 PubMed 和 EMBASE 数据库至 2018 年 1 月 19 日,纳入 12 项研究共 660 例患者,评估治疗前 MTV 或 TLG 作为预后因素,以 EFS 和 OS 为终点,效应量以 HR 表示并合并。

诊断标准与关键数值

  • 高 MTV 患者 EFS 合并 HR 为 5.89(95%CI 3.85-9.01,p<0.00001),OS 合并 HR 为 6.62(95%CI 3.44-12.73,p<0.00001);高 TLG 患者 EFS 合并 HR 为 5.82(95%CI 3.62-9.35,p<0.00001),OS 合并 HR 为 7.75(95%CI 3.48-17.27,p<0.00001);亚组分析中 MTV 和 TLG 对 EFS 的合并 HR 分别为 5.08-7.30 和 4.80-15.83。

局限性

  • 研究间存在临床和方法学差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study is to perform a systematic review and meta-analysis of volume-based 18F-FDG PET/CT parameters regarding the prognostic value of metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in patients with uterine cervical cancer.

MATERIALS AND METHODS: The PubMed and EMBASE databases were systematically searched until January 19, 2018. We included studies that evaluated pretreatment MTV or TLG as a prognostic factor in uterine cervical cancer with event-free (EFS) and overall survival (OS) as the endpoints. Effect sizes of the prognostic value of MTV and TLG were measured in terms of hazard ratio (HR) and were meta-analytically pooled. Multiple subgroup analyses stratified to clinicopathologic and PET/CT variables were performed to explore heterogeneity.

RESULTS: Twelve studies including 660 patients were included. Prognoses were worse in patients with high MTV and TLG, with pooled HRs of 5.89 (95% CI, 3.85-9.01; p < 0.00001) and 5.82 (95% CI, 3.62-9.35; p < 0.00001), respectively, for EFS and 6.62 (95% CI, 3.44-12.73; p < 0.00001) and 7.75 (95% CI, 3.48-17.27; p < 0.00001), respectively, for OS. At multiple subgroups analyses, the prognostic values of MTV and TLG for EFS were consistently significant, with pooled HRs of 5.08-7.30 and 4.80-15.83, respectively.

CONCLUSION: Volume-based FDG PET/CT parameters were significant prognostic factors in patients with uterine cervical cancer. In spite of clinical and methodologic differences across the studies, patients with high MTV or TLG had a higher risk of adverse events or death.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Han S, Kim H, Kim YJ, et al. Prognostic Value of Volume-Based Metabolic Parameters of 18F-FDG PET/CT in Uterine Cervical Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol. 2018. PMID: 30207790. doi:10.2214/AJR.18.19734

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。